James M. Donegan

James (Jim) M. Donegan is the Co-Founder, Chairman, and CEO of Flxion Medical, a company dedicated to developing low-cost injectable solutions for emergency civilian use, including Epinephrine and Naloxone.

Career Highlights:

•Former Co-Founder & CEO, Meta Energy Group and Oil Meta Trust

•Founder & President, JMD Financial Consultant Group (energy and fuel advisory)

•Co-Founder & CEO, Med-Design Corporation (publicly traded medical device company) 1995–2005

•Played a key role in facilitating the Needlestick Safety and Prevention Act (NSPA), signed by President Bill Clinton

•Executive roles at Chase Manhattan Bank and Kidder Peabody

•Specialized in structured investment products and financial futures

Licenses Held:

•Series 3 (Commodities – NCFE)

•Series 4 (Registered Options Principal – ROP)

•Series 7 (Securities – FINRA)

•Series 63 (State Registration – Blue Sky Laws)

Recognition & Speaking:

•Entrepreneur of the Year Finalist, 1998 (Philadelphia Business Association)

•Excalibur Award Nominee, 1993 (Chase Manhattan Bank)

•Guest lecturer at USC MBA Program on financial derivatives and trading strategies